Last Updated : August 27, 2024
Details
FilesGeneric Name:
teriflunomide
Project Status:
Active
Therapeutic Area:
Multiple Sclerosis (MS)
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0752-000
Call for patient/clinician input closed:
NOC Status at Filing:
N/A
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
Radiologically Isolated Syndrome (RIS)
Submission received | 11-Jul-24 |
---|
Files
Last Updated : August 27, 2024